Top news of the week: 05.05.2020.
Biotechnology, Clinical trial, Vaccination, Drug, Oncology, Mesenchymal stem cell
Startups
RT @matthewherper: Big Pharma could boost its reputation with a solid response to Covid-19.
Awesome to see @John_LaMattina in STAT!
https://t.co/igpn0S6ew3
OpenBig Pharma could boost its reputation with a solid response to Covid-19
Although Big Pharma is investing millions of R&D dollars to find a vaccine or therapy for Covid-19 the industry is being viewed with suspicion and scorn.
Dr. Kuok Meng-Han, the son of Singapore billionaire Kuok Khoon Hong, leads biotech labs to export COVID-19 test kits https://t.co/esn9HvQcWv https://t.co/opS8jVz25b
OpenSingapore Billionaire’s Son Leads Biotech Labs To Export COVID-19 Test Kits
As Singapore extends its semi lockdown circuit breaker to June 1st in the face of spiking coronavirus cases, local biotech firms are racing against time to work on solutions that can help ...
One IPO attempt pulled, a drug on partial hold and a pandemic, but ADC tries again https://t.co/XswlSnDfBB https://t.co/SwC8805l3g
OpenOne IPO attempt pulled, a drug on partial hold and a pandemic, but ADC tries again
One of the more surprising elements of the pandemic is how well biotech IPOs have managed, and now Swiss startup ADC Therapeutics is hoping for a second-time lucky attempt despite COVID-19.
RT @AndyBiotech: #COVID19 vaccine development is moving forward at an unprecedented speed as we pin our best hope on a #coronavirus vaccine for a return to normal life
Excellent story in NYT on the global race
https://t.co/hIw81T2I5r
Nice timeline via @BioCentury
https://t.co/o8LlTmLebN https://t.co/vjotbFvOqJ
OpenEnd of the beginning for COVID-19 vaccines
It has been a hundred days and change since Chinese researchers posted the genetic sequence for the SARS-CoV2 virus to a public database, setting off the biggest and fastest race to create ...
RT @claydumas: “Eat more garlic” was my French grandma’s solution to pretty much everything. Turns out that applies to climate, too. Garlic-based cow feed additive from @mootral cuts methane emissions from dairy cattle by a third, and my grandma is vindicated once again. https://t.co/0rFRkwxCR0
OpenThe Business of Burps: Scientists Smell Profit in Cow Emissions
Cattle produce more methane than many large countries. A solution could be an ecological and financial breakthrough — and a Swiss biotech company may be on the cusp.
@GZuckerman @statnews October he mentioned as their "moonshot," but he did sound rather confident about it. They completed dosing of first cohort of 12 patients in Germany in Phase 1/2 trial https://t.co/FZGYgJkyu9
OpenPfizer, BioNTech finish dosing in COVID-19 vax test; emergency use could start in the fall
Pfizer and partner BioNTech are keeping pace with the speed of the sweeping pandemic as they finish dosing in the first cohort of their COVID-19 inoculation test.
Melbourne-based biotech company Mesoblast announced that it’s begun enrolling up to 300 patients for a randomized, controlled study of its stem cell therapy https://t.co/jUT0Tv94yP by @TheAlexKnapp https://t.co/wNTXK7sYsb
OpenClinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon
Melbourne-based biotech company Mesoblast will enroll up to 300 COVID-19 patients for a randomized, controlled study of its stem cell therapy.
Disappointments In Alzheimer's Therapeutic Development
Nice interview,@John_LaMattina . The fact that we should expect startups and not large pharma to come up with dif approaches comes down to a risk-taking capability perspective. Innovation will be key https://t.co/bgO4ohjMNB
OpenDisappointments In Alzheimer's Therapeutic Development — A Conversation With John LaMattina
A question from a reader for Life Science Leader's popular monthly Ask The Board column, prompts a Q&A discussion with John LaMattina, Ph.D.,...